Effect of silk fibroin peptide derived from silkworm Bombyx mori on the anti-inflammatory effect of Tat-SOD in a mice edema model
1
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
We investigated whether silk fibroin peptide derived from the silkworm, Bombyx mori, could inhibit inflammation and enhance the anti-inflammatory activity of Tat-superoxide dismutase (Tat-SOD), which was previously reported to effectively penetrate various cells and tissues and exert anti-oxidative activity in a mouse model of inflammation. Inflammation was induced by topical treatment of mouse ears with 12-O-tetradecanoylphorbol-13-acetate (TPA). Histological, Western blot, and reverse transcription-polymerase chain reaction data demonstrated that silk fibroin peptide or Tat-SOD alone could suppress elevated levels of cyclooxygenase-2, interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha induced by TPA. Moreover, silk fibroin peptide significantly enhanced the anti-inflammatory activity of Tat-SOD, although it had no influence on in vitro and in vivo transduction of Tat-SOD. Silk fibroin peptide exhibited anti-inflammatory activity in a mice model of inflammation. Therefore,silk fibroin peptide alone or in combination with Tat-SOD might be used as a therapeutic agent for various inflammatory diseases. [BMB reports 2011; 44(12): 787-792]
Abstract
We investigated whether silk fibroin peptide derived from the silkworm, Bombyx mori, could inhibit inflammation and enhance the anti-inflammatory activity of Tat-superoxide dismutase (Tat-SOD), which was previously reported to effectively penetrate various cells and tissues and exert anti-oxidative activity in a mouse model of inflammation. Inflammation was induced by topical treatment of mouse ears with 12-O-tetradecanoylphorbol-13-acetate (TPA). Histological, Western blot, and reverse transcription-polymerase chain reaction data demonstrated that silk fibroin peptide or Tat-SOD alone could suppress elevated levels of cyclooxygenase-2, interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha induced by TPA. Moreover, silk fibroin peptide significantly enhanced the anti-inflammatory activity of Tat-SOD, although it had no influence on in vitro and in vivo transduction of Tat-SOD. Silk fibroin peptide exhibited anti-inflammatory activity in a mice model of inflammation. Therefore,silk fibroin peptide alone or in combination with Tat-SOD might be used as a therapeutic agent for various inflammatory diseases. [BMB reports 2011; 44(12): 787-792]
참고문헌 (27)
- Wu, J. N, "An illustrated Chinese material medica", pp.140~141 (2005), Oxford
- Jwa-Young Kim, "Low molecular weight silk fibroin increases alkaline phosphatase and type I collagen expression in MG63 cells", BMB reports, 43(1), pp.52~56 (2010), 한국생화학분자생물학회
- Lu, S, "Stabilization of enzymes in silk films", Biomacromolecules, 10, pp.1032~1042 (2009)
- Hyun, C. K, "Soluble fibroin enhances insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes", J. Nutr, 134, pp.3257~3263 (2004)
- Igarashi, K, "Blood pressure-depressing activity of a peptide derived from silkworm fibroin in spontaneously hypertensive rats", Biosci. Biotechnol. Biochem, 70, pp.517~520 (2006)
- Dietz, G. P, "Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research", Curr. Pharm. Biotechol, 11, pp.167~174 (2010)
- Wadia, J. S, "Protein transduction technology", Curr. Opin. Biotechnol, 13, pp.52~56 (2002)
- Liochev, S. I, "Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase", Free Radic. Biol. Med, 48, pp.1565~1569 (2010)
- 김준, "Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice", Toxicology, 276, pp.192~197
- Choi, H. S, "PEP-1-SOD fusion protein efficiently protects against paraquat- induced dopaminergic neuron damage in a Parkinson disease mouse model", Free Radic. Biol. Med, 41, pp.1058~1068 (2006)
- Kim, D. W, "Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult", FREE RADICAL BIOLOGY AND MEDICINE, 48, pp.969~977 (2010), Elsevier Science
- -2-methoxybenzamide, enhances the transduction efficiency of PEP-1-ribosomal protein S3 in vitro and in vivo, "BMB reports", 2011, 329~334, pp.생화학분자생물학회
- Sun Hwa Lee, "Enhancement of HIV-1 Tat fusion protein transduction efficiency by bog blueberry anthocyanins", BMB reports, 43(8), pp.561~566 (2010), 생화학분자생물학회
- 김대원, "HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic β cells in vitro and in vivo", Free Radical Biology and Medicine, 37(3), pp.339~349, Elsevier BV
- Floyd, R. A, "Role of oxygen free radicals in carcinogenesis and brain ischemia", FASEB J, 4, pp.2587~2597 (1990)
- Stanley, P. L, "Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate", Skin Pharmacology, 42, pp.262~271 (1991)
- Bickers, D. R, "Oxidative stress in the pathogenesis of skin disease", J. Invest. Dermatol, 126, pp.2565~2575 (2006)
- Grilli, M, "Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway", Cell Death Differ, 6, pp.22~27 (1999)
- Baldwin, Jr, A. S, "Series introduction: The transcription factor NF-κB and human disease", J. Clin. Invest, 107, pp.3~6 (2001)
- Nathan, C, "Points of control in inflammation", Nature, 420, pp.846~852 (2002)
- Mates, J. M, "Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology", Toxicology, 83, pp.83~104 (2000)
- Muzykantov, V. R, "Targeting of superoxide dismutase and catalase to vascular endothelium", J. Control. Release, 7, pp.1~21 (2001)
- Wang, F, "Current and potential inflammation targeted therapies in head and neck cancer", Curr. Opin. Pharmacol, 9, pp.389~395 (2009)
- Egbers, J. H, "Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis", Cancer Res, 68, pp.1443~1450 (2008)
- Van Waes, C, "Nuclear factor-kappaB in development, prevention, and therapy of cancer", Clin. Cancer Res, 13, pp.1076~1082 (2007)
- Aggarwal, S, "Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling", Int. J. Cancer, 111, pp.679~692 (2004)
- Dhillon, N, "Phase II trial of curcumin in patients with advanced pancreatic cancer", Clin. Cancer Res, 14, pp.4491~4499 (2008)